Atlas Trials

Low Antimonial Dosage in American Mucosal Leishmaniasis

Clinical trial NCT01301937 · UNKNOWN

Trial details

NCT number
NCT01301937
Sponsor
Oswaldo Cruz Foundation
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Mucosal LeishmaniasisMucocutaneous Leishmaniasis
Start date
2008-10-01
Primary completion
2020-12-01
Enrollment
76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.